ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 66 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $414 | -99.6% | 49,294 | +165.4% | 0.03% | +255.6% |
Q3 2022 | $99,000 | -23.8% | 18,573 | -42.7% | 0.01% | -30.8% |
Q4 2021 | $130,000 | -10.3% | 32,401 | +152.7% | 0.01% | -7.1% |
Q2 2021 | $145,000 | +57.6% | 12,824 | -4.5% | 0.01% | +40.0% |
Q4 2020 | $92,000 | -56.2% | 13,428 | -52.6% | 0.01% | -72.2% |
Q3 2020 | $210,000 | +128.3% | 28,324 | +78.3% | 0.04% | +300.0% |
Q4 2019 | $92,000 | -4.2% | 15,886 | -0.3% | 0.01% | +50.0% |
Q2 2019 | $96,000 | -90.5% | 15,932 | -78.2% | 0.01% | -90.3% |
Q3 2018 | $1,008,000 | +869.2% | 73,023 | +458.8% | 0.06% | +1140.0% |
Q2 2018 | $104,000 | – | 13,068 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |